An international research team has succeeded in characterising different immune responses of tuberculosis patients and identifying groups of patients who either showed a very low or a very strong
Please use the image only in connection with this press release.
Infection with SARS-CoV-2 leaves some people almost unaffected, while others develop life-threatening COVID-19 symptoms. So far, we do not understand exactly why symptoms and disease severity
Bloodstream infections (BSI) are serious bacterial infections associated with high mortality. A research team developed the clinical BLOOMY* scores in order to identify risk factors and thus be able
Please use this image only in connection with this press release.
Despite improved methods of treatment, an infection with the hepatitis C virus still leads to approximately 400,000 deaths worldwide each year. The development of a vaccine is urgently required, but
The Epstein-Barr virus (EBV) has been known for some time to play a part in a range of diseases. A current US study has now shown a close link between EBV and multiple sclerosis. DZIF scientists at
This year, the German Center for Infection Research (DZIF) is honouring the medical scientist and clinical virologist Prof. Ulrike Protzer for her scientific achievements. The prize is endowed with
Bitte verwenden Sie dieses Bild nur im Zusammenhang mit dieser Pressemitteilung.
While the highly infectious SARS-CoV-2 Delta variant has already become predominant in Germany and in most European nations, little was known about its spread in Africa. German Center for Infection
The intestine of a healthy person contains hundreds of different bacteria that provide efficient protection against infections. However, if the equilibrium of this community, known as the microbiota
Enterobacteria such as Escherichia coli or Klebsiella pneumoniae are dreaded hospital germs that can cause serious intestinal and urinary tract infections. The risk of infection with these pathogens
Please use the image only in conjunction with this message.
Paediatrician and DZIF scientist Dr Julia Pagel, Universität zu Lübeck, will receive EUR 50,000 to expand her research on lung diseases in infants. The prize is awarded by the North German Cluster of